Marilyn J. Lemmon
- Molecular Biology
- Cancer Research top 5%
- Oncology top 10%
- Genetics top 5%
- Biotechnology top 2%
- Co-authors
- Elaine M. ZemanJulia BrownV.Kate HirstJeremy BrownWilliam W. LeeJeffrey M. BrownJ. Martin BrownCarla Heise
- Topics
- Cancer, Hypoxia, and Metabolism (10 papers)Cancer Research and Treatments (9 papers)Virus-based gene therapy research (5 papers)
- Cited by
- Cancer ResearchBiotechnologyOncology
- Journals
- Cancer CellInternational Journal of Radiation Oncology*Biology*PhysicsRadiotherapy and Oncology
- Partner nations
- United StatesUnited KingdomItaly
In The Last Decade
Marilyn J. Lemmon
21 papers receiving 1.4k citations
Peers
Comparison fields: 5 of 83
- Molecular Biology 638
- Cancer Research 579
- Oncology 348
- Genetics 343
- Biotechnology 310
Countries citing papers authored by Marilyn J. Lemmon
This map shows the geographic impact of Marilyn J. Lemmon's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Marilyn J. Lemmon with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Marilyn J. Lemmon more than expected).
Fields of papers citing papers by Marilyn J. Lemmon
This network shows the impact of papers produced by Marilyn J. Lemmon. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Marilyn J. Lemmon. The network helps show where Marilyn J. Lemmon may publish in the future.
Co-authorship network of co-authors of Marilyn J. Lemmon
This figure shows the co-authorship network connecting the top 25 collaborators of Marilyn J. Lemmon. A scholar is included among the top collaborators of Marilyn J. Lemmon based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Marilyn J. Lemmon. Marilyn J. Lemmon is excluded from the visualization to improve readability, since they are connected to all nodes in the network.
All Works
| # | Work | Indexed citations |
|---|---|---|
| 1 | 0 | |
| 2 | 2 | |
| 3 | 150 | |
| 4 | Efficacy with a replication-selective adenovirus plus cisplatin-based chemotherapy: dependence on sequencing but not p53 functional status or route of administration. | 87 |
| 5 | Anaerobic bacteria as a delivery system for cancer gene therapy: in vitro activation of 5-fluorocytosine by genetically engineered clostridia. | 134 |
| 6 | 34 | |
| 7 | 23 | |
| 8 | 25 | |
| 9 | 6 | |
| 10 | 41 | |
| 11 | 77 | |
| 12 | 13 | |
| 13 | Potentiation by the hypoxic cytotoxin SR 4233 of cell killing produced by fractionated irradiation of mouse tumors. | 150 |
| 14 | 25 | |
| 15 | 55 | |
| 16 | 75 | |
| 17 | 65 | |
| 18 | 43 | |
| 19 | 327 | |
| 20 | 31 |
About Marilyn J. Lemmon
Marilyn J. Lemmon is a scholar working on Biotechnology, Cancer Research and Pharmaceutical Science, having authored 22 papers that have together received 1.4k indexed citations. Recurring topics across this work include Cancer, Hypoxia, and Metabolism (10 papers), Cancer Research and Treatments (9 papers) and Virus-based gene therapy research (5 papers). The work is most often cited by research in Cancer Research (579 citations), Biotechnology (310 citations) and Oncology (348 citations). Marilyn J. Lemmon has collaborated with scholars based in United States, United Kingdom and Italy. Frequent co-authors include Elaine M. Zeman, Julia Brown, V.Kate Hirst, Jeremy Brown, William W. Lee, Jeffrey M. Brown, J. Martin Brown, Carla Heise, David H. Kirn and Michael R. Horsman. Their work appears in journals such as Cancer Cell, International Journal of Radiation Oncology*Biology*Physics and Radiotherapy and Oncology.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.